← Leaderboards
Clodagh O'Shea
Salk Institute For Biological Studies
$8,849,066
Attributed
$11,684,866
Total exposure
7
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.4M · FY2009–25$2M$1.5M$1M$500K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$11,684,866 · 7
By mechanism
R01$8,021,430 · 3
U01$3,337,758 · 2
R43$301,012 · 1
P41$24,666 · 1
Top collaborators
- Mark H Ellisman6 shared
- Alan Saghatelian4 shared
- Lyudmila Bazhenova2 shared
- Jose Manuel Morachis2 shared
Most similar at Salk Institute For Biological Studies
Same institution · by research overlap
- Geoffrey Myles Wahl$25,627,017
Others in their field
Top investigators on “Proteins”
- David Heimbrook · Leidos Biomedical Research, Inc.$354,061,551
- Randall J Bateman · Washington University$187,292,085
- Paul S. Aisen · Cognition Therapeutics, Inc.$175,382,342
- Reisa A. Sperling · Banner Health$145,046,481
- Barton F Haynes · Duke University$136,029,850
- Joseph L Goldstein · University Of Texas Sw Med Ctr/Dallas$102,433,280
Research focus
ProteinsViralNeoplastic CellMalignant NeoplasmsCellsStructureInsightMutantNuclearPathway InteractionsAdenovirusesMutationEngineeringCell NucleusTumorBiologyTechnologyCancer TherapyResponseViral ProteinsTherapeutic TargetVirusPolymersGenomics
Grant awards (28)
The Discovery of Human Peptide Encoding Genes$483,123
R01 · FY2025 · GM
The Discovery of Human Peptide Encoding Genes$483,123
R01 · FY2024 · GM
The Discovery of Human Peptide Encoding Genes$483,123
R01 · FY2023 · GM
The Discovery of Human Peptide Encoding Genes$483,123
R01 · FY2022 · GM
Imaging local and global chromatin structure as a 3D continuum within the nucleus$600,000
U01 · FY2019 · DA · contact PI
Defining Critical p53 Therapeutic Targets and Mechanisms$423,405
R01 · FY2019 · CA · contact PI
Imaging local and global chromatin structure as a 3D continuum within the nucleus$337,758
U01 · FY2019 · DA · contact PI
Imaging local and global chromatin structure as a 3D continuum within the nucleus$600,000
U01 · FY2018 · DA · contact PI
Defining Critical p53 Therapeutic Targets and Mechanisms$436,500
R01 · FY2018 · CA · contact PI
Viral oncoproteins: Revealing novel structural motifs to target tumor suppressors$402,550
R01 · FY2018 · CA · contact PI
Imaging local and global chromatin structure as a 3D continuum within the nucleus$600,000
U01 · FY2017 · EB · contact PI
Defining Critical p53 Therapeutic Targets and Mechanisms$436,500
R01 · FY2017 · CA · contact PI
Viral oncoproteins: Revealing novel structural motifs to target tumor suppressors$402,550
R01 · FY2017 · CA · contact PI
Imaging local and global chromatin structure as a 3D continuum within the nucleus$600,000
U01 · FY2016 · EB · contact PI
Defining Critical p53 Therapeutic Targets and Mechanisms$436,500
R01 · FY2016 · CA · contact PI
Viral oncoproteins: Revealing novel structural motifs to target tumor suppressors$402,550
R01 · FY2016 · CA · contact PI
Imaging local and global chromatin structure as a 3D continuum within the nucleus$600,000
U01 · FY2015 · EB · contact PI
Defining Critical p53 Therapeutic Targets and Mechanisms$436,500
R01 · FY2015 · CA · contact PI
Viral oncoproteins: Revealing novel structural motifs to target tumor suppressors$402,550
R01 · FY2015 · CA · contact PI
Viral oncoproteins: Revealing novel structural motifs to target tumor suppressors$402,550
R01 · FY2014 · CA · contact PI
Defining critical p53 therapeutic targets and mechanisms$358,343
R01 · FY2013 · CA · contact PI
Defining critical p53 therapeutic targets and mechanisms$381,215
R01 · FY2012 · CA · contact PI
Ading color to cancer, adenovirus and flow cytometry to identify and capture CTCs$152,152
R43 · FY2012 · CA
Defining critical p53 therapeutic targets and mechanisms$381,215
R01 · FY2011 · CA · contact PI
Ading color to cancer, adenovirus and flow cytometry to identify and capture CTCs$148,860
R43 · FY2011 · CA
A NOVEL NUCLEAR STRUCTURE THAT SILENCES P53 ACTIVITY$24,666
P41 · FY2011 · RR · contact PI
Defining critical p53 therapeutic targets and mechanisms$393,005
R01 · FY2010 · CA · contact PI
Defining critical p53 therapeutic targets and mechanisms$393,005
R01 · FY2009 · CA · contact PI